更正：ubrogepant：首次批准。
Correction to: Ubrogepant: First Approval.
作者信息
Scott Lesley J
机构信息
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
出版信息
Drugs. 2020 Apr;80(5):523. doi: 10.1007/s40265-020-01292-1.
The article Ubrogepant: First Approval, written by Lesley J. Scott, was originally published published Online First without Open Access. After publication online Allergan Sales, LLC requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Allergan Sales, LLC. The article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit original author(s) and the source, provide a link to the Creative Commons licence and indicate if changes were made.
文章《乌布罗格潘：首次获批》，作者莱斯利·J·斯科特，最初以非开放获取形式在线优先发表。在线发表后，艾尔建销售有限责任公司要求将该文章设为开放选择，使其成为开放获取出版物。出版后开放获取由艾尔建销售有限责任公司资助。本文即刻依据知识共享署名4.0国际许可协议（http://creativecommons.org/licenses/by/4.0/）分发，该协议允许在任何媒介或格式下使用、复制、改编、分发和复制，只要您适当引用原作者和来源，提供知识共享许可协议的链接，并表明是否有改动。
Zotero 插件